企業プロフィール
Immunic 株価・ニュース・カタリスト
- ティッカー:
- IMUX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Germany
株価パフォーマンス
16.46 USD (-0.24%)
終値
最終更新: 2026年8月24日
199M USD
時価総額
株価変動の要因
As of Aug 24, 2026, IMUX was little changed and closed at $16.46. No new same-company headline was identified in the current news window.
企業概要
事業概要
Immunic is a biotechnology company focused on immune-mediated disease and small-molecule immunology. Its pipeline is aimed at inflammatory and autoimmune disorders.
所在地とセクター分類
Headquartered in Germany and listed on NASDAQ as an ADR, Immunic has a global specialty-biopharma profile.
ビジネスモデルの特徴
The company depends on clinical data, target validation, and the ability to create a differentiated inflammation franchise.
バイオ業界での位置付け
Immunic is a catalyst-sensitive immunology name whose stock reacts to early clinical and mechanistic signals.
今後のカタリスト
- Immunic’s catalysts are vidofludimus calcium and the autoimmune / neuroinflammation pipeline, where each update can change the company’s credibility quickly. The market still needs a stronger human-data story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。